![Hui Li](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Hui Li, who previously worked as General Manager & Director at Sinopharm Group Co., Ltd. and later as General Manager & Director at China National Medicines Co., Ltd. from 2018 to 2021.
| Unternehmen | Position | Ende |
|---|---|---|
| CHINA NATIONAL MEDICINES CORPORATION LTD. | Vorstandsvorsitzender | 13.01.2021 |
| SINOPHARM GROUP CO. LTD. | Vorstandsvorsitzender | 12.01.2021 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 2 |
|---|---|
Sinopharm Group Co., Ltd.
 Sinopharm Group Co., Ltd. Medical DistributorsDistribution Services Distributes pharmaceuticals and medical devices & operates retail pharmacies | Distribution Services |
China National Medicines Co., Ltd.
 China National Medicines Co., Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures Western and Chinese medicines | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
Wählen Sie MarketScreener 
